Daniel K. Nomura

Daniel K. Nomura

Private Equity Investor chez
The Column Group LLC
Health Technology
Consumer Services
Finance

Profil

Daniel K.
Nomura
was the founder of Frontier Medicines Corp., founded in 2018, where the title held was Chemistry Professor.
Dr. Nomura was the founder of Vicinitas Therapeutics, Inc., founded in 2022, where the title held was Director.
Current jobs include serving on the Scientific Advisory Board at The University of Texas M.D.
Anderson Cancer Center, Mark Foundation, Oerth Bio LLC, Apertor Pharmaceuticals, Inc., Photys Therapeutics, Inc., and Ecto Therapeutics.
Additionally, Dr. Nomura holds the title of iPartner at The Column Group LLC since 2023 and Advisory Partner at AH Capital Management LLC since 2023.
Education history includes undergraduate and doctorate degrees from the University of California, Berkeley, conferred in 2003 and 2008 respectively.

Postes actifs de Daniel K. Nomura

SociétésPosteDébut
Private Equity Investor 01/08/2023
Consultant / Advisor 01/03/2023
Consultant / Advisor -
Consultant / Advisor -
Consultant / Advisor -
Consultant / Advisor -
Consultant / Advisor -

Anciens postes connus de Daniel K. Nomura

SociétésPosteFin
Fondateur -
Fondateur -
Voir l'expérience en détail de Daniel K. Nomura

Formation de Daniel K. Nomura

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

98

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Consumer Services

Consumer Services

Finance

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Daniel K. Nomura
🔇